﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/jury-verdicts/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/jury-verdicts/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/therapeutic-biological-products/447212/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/safety-information-therapeutic-biological-products/447210/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/therapeutic-biological-products-approvals/447211/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/bivalirudin-marketed-as-angiomax-consumer-information-sheet/447218/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/abbokinase-urokinase-package-insert/447213/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/urokinase-abbokinase-product-approval-information-new-drugapplication/447214/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/update-on-abbokinase-urokinase/447215/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/update-on-abbokinase-urokinase/447216/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/important-drug-warning-safety-information-regarding-the-use-of-abbokin/447217/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/fda-alerts/cber-urokinase-abbokinase-abbott-laboratories/447219/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/news-articles/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/news-articles/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/msn/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/msn/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/thank-you.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/disclaimer.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/ContactUs.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/local/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://fdadrugs.legalview.com/legal-issue/abbokinase/local/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
